NewMarket (FRA:UG9) ROCE %: 20.97% (As of Mar. 2026)

What is NewMarket ROCE %?

NewMarket FRA:UG9 79 ROCE % is 20.97% as of Mar. 2026. GuruFocus rates FRA:UG9 with a GF Score™ of 79/100 and a GF Value™ of €486.04 (Significantly Overvalued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. NewMarket's annualized ROCE % for the quarter that ended in Mar. 2026 was 20.97%.

NewMarket (FRA:UG9) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

NewMarket ROCE % Related Terms

NewMarket ROCE % Historical Data

* Premium members only.

The historical data trend for NewMarket's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NewMarket ROCE % Chart

NewMarket Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

16.88

20.69

26.41

27.76

19.51

NewMarket Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															24.62	21.78	20.33	16.71	20.97

79GF Score

NewMarket Corp FRA:UG9

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

NewMarket ROCE % Calculation

NewMarket's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	512.618	/	( ( (2988.712 - 357.626)	+	(2982.565 - 358.064) )	/ 2 )
	=	512.618	/	( (2631.086	+	2624.501)	/ 2 )
	=	512.618	/	2627.7935
	=	19.51 %

NewMarket's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	555.072	/	( ( (2982.565 - 358.064)	+	(3031.226 - 360.926) )	/ 2 )
	=	555.072	/	( ( 2624.501	+	2670.3 )	/ 2 )
	=	555.072	/	2647.4005
	=	20.97 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 20.97% mean?

NewMarket (FRA:UG9) has a ROCE % of 20.97% as of Mar. 2026.

Is NewMarket's ROCE % too high?

NewMarket's current ROCE % is 20.97%. The Chemicals industry median ROCE % is 6.42. NewMarket's value of 20.97% is 226.6% above this industry median. Overall, NewMarket has a GF Score™ of 79/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does NewMarket's ROCE % compare to AXTA and EMN?

NewMarket's ROCE % of 20.97% can be compared against companies in the Chemicals industry. The industry median ROCE % is 6.42. NewMarket's value of 20.97% is 226.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Chemicals company?

The median ROCE % among Chemicals companies is 6.42, based on 1,595 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NewMarket's current ROCE % of 20.97% is 226.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Chemicals industry, the median ROCE % is 6.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NewMarket's current ROCE % is 20.97%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is NewMarket stock overvalued right now?

Based on GuruFocus' analysis, NewMarket (FRA:UG9) is currently considered Significantly Overvalued. The stock's GF Value™ is €486.04, compared to a current price of €680.00 — trading 39.9% above its estimated fair value. The current ROCE % is 20.97% and 226.6% above the Chemicals industry median of 6.42. NewMarket's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For NewMarket (FRA:UG9), the current ROCE % is 20.97% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NewMarket (FRA:UG9) Overvalued in 2026?

Based on GuruFocus' analysis, NewMarket stock appears to be overvalued. The current stock price of €680.00 is trading 39.9% above its estimated GF Value™ of €486.04. GuruFocus considers NewMarket to be Significantly Overvalued.

Key valuation signals for FRA:UG9:

ROCE %: 20.97%
GF Value™: €486.04 vs. price of €680.00 (39.9% above fair value)
GF Score™: 79/100 with 5 warning signs
Industry Position: 226.6% above the Chemicals median

No single metric tells the full story. See the FRA:UG9 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

NewMarket Business Description

Industry Basic Materials Chemicals

Comparable Companies AXTA EMN PRM BCPC SXT CBT ESI FUL CC AVNT LIN XPAR:AI SHW ECL APD XSWX:GIVN SHSE:600309 XSWX:SIKA SZSE:002466 OCSE:NSIS B

Other Exchanges NEU:USA UG9:Germany

Address 330 South Fourth Street, Richmond, VA, USA, 23219-4350

Website https://www.newmarket.com

NewMarket Corp is a holding company that, through its subsidiaries, manufactures and sells petroleum additives used in lubricating oils and fuels to enhance performance. The company operates through two segments: petroleum additives, mainly represented by Afton, where lubricant additives improve the efficiency and durability of base fluids and fuel additives help meet fuel specifications and improve fuel performance, and specialty materials, represented by AMPAC and Calca, including the antiknock compounds business of Ethyl, where primary raw materials include electricity, sodium chlorate, ammonia, chlorine, caustic, and hydrochloric acid, with graphite used in electrolytic cells. The company has operations in North America, Latin America, Asia Pacific, and EMEAI regions.

79GF Score

Get the complete analysis for FRA:UG9

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€680.00

Price

€486.04

GF Value

View FRA:UG9 Analysis

See ROCE % data for all stocks →